Key Points Doximity Inc. NASDAQ: DOCS is a social networking platform exclusively designed for U.S. healthcare professionals. It's a cross between Meta Platforms Inc. NASDAQ: META owned Facebook and Microsoft Co. NASDAQ: MSFT owned LinkedIn. The community has grown to over 580,000 medical providers as the company has integrated artificial intelligence (AI) and automation functions. Doximity competes with telehealth platforms in the medical sector, such as Teladoc Health Inc. NYSE: TDOC, American Well Co. NY ...

The case is Kissler v. Doximity, Inc., et al., 24-cv-02281. About ClaimsFiler NEW ORLEANS, May 17, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company's shares between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action is pending in the United S ...

Key Takeaways Doximity shares jumped Friday morning after the digital medical networking company topped quarterly earnings forecasts, provided a better-than-expected current-quarter outlook, and unveiled a stock buyback program. Subscription revenue in the fiscal fourth quarter was $112.7 million, a 9% increase from a year earlier, helping to boost top-line growth. Monitor the $28 level, an area where the stock may find overhead resistance from a horizontal line connecting a series of price action over the ...

Investors found a lot to like about the healthcare technology company's latest quarterly update. Shares of Doximity (DOCS 16.60%) were skyrocketing 15.9% higher as of 10:54 a.m. ET on Friday. The big gain came after the healthcare technology company announced its fiscal 2024 fourth-quarter and full-year results following market close on Thursday. Doximity reported fiscal Q4 revenue of $118.1 million, a 6% year-over-year increase. This topped the consensus revenue estimate of roughly $116.5 million. The comp ...

Stanislav Berenshteyn Great, thank you. Thanks, Stan. And our next question comes from the line of Stephanie Davis with Barclays. Stephanie, please go ahead. Stephanie Davis And given you've now rolled it out to an extra 10% of your client base, and I'm going to get the initial 10% of clients were probably larger clients. What are you paying the closest attention to in terms of potential feedback you could be getting since this is more so going to be a product for the lower end clients? And again, the abili ...

Doximity (DOCS) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.24 per share when it actually produced earnings of $0.29, delivering a surprise of 20.83%. Over the last four quarte ...

Class Period: February 9, 2022 – April 1, 2024 Lead Plaintiff Deadline: June 17, 2024 LOS ANGELES, May 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the ...

The Doximity class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that defendants repeatedly touted Doximity's business prospects and the sustainability of Doximity's revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on Doximity as well as its reliance on "upselling" products and services (such as additional advertising) to existing customers to sustain Do ...

RADNOR, Pa., May 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States Distric ...

In its upcoming report, Doximity (DOCS) is predicted by Wall Street analysts to post quarterly earnings of $0.20 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $116.46 million, representing a year-over-year increase of 5%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company anno ...